Oragenics, Inc. Announces Public Offering Pricing Details
![Oragenics, Inc. Announces Public Offering Pricing Details](https://investorshangout.com/images/blog/ihnews-Oragenics%2C%20Inc.%20Announces%20Public%20Offering%20Pricing%20Details.jpg)
Oragenics, Inc. Unveils Public Offering Pricing
Oragenics, Inc. (NYSE American: OGEN), a biotechnology company specializing in innovative intranasal medications aimed at treating neurological disorders, has shared significant news regarding its recent public offering. Based in Sarasota, Florida, the company has entered into a placement agreement for the sale of over 8 million shares of its common stock. The offered shares are priced at $0.55 each, or $0.549 per pre-funded warrant in lieu of shares.
Details of the Offering
The anticipated gross proceeds from this offering are projected to be around $4.45 million, a sum that will help fortify the company's objectives before accounting for placement agent fees and other related expenses. The funds generated from this public offering are earmarked for the continued development of ONP-002, one of Oragenics' key product candidates, alongside general operational expenses and working capital needs.
Placement Agent Information
Dawson James Securities, Inc. has been appointed as the sole placement agent for this offering, providing support in facilitating this capital raise for Oragenics.
Regulatory Compliance and Prospectus Details
This public offering is being conducted under a registration statement on Form S-1, which has been filed with and declared effective by the U.S. Securities and Exchange Commission (SEC). The offering details will be enclosed in a written prospectus, ensuring complete transparency in the process.
Accessing the Offering Documents
Prospective investors can access the relevant prospectus documents, which will provide comprehensive details about the terms of the offering, on the SEC's official website. Additionally, these documents can be requested from Dawson James Securities, Inc., ensuring that all interested parties have the necessary information for their investment decisions.
About Oragenics and Their Mission
Oragenics is at the forefront of biotechnology, focusing on transforming the treatment landscape for neurological conditions via nasal delivery systems. Their product pipeline includes treatments aimed at mild traumatic brain injury (mTBI) and Niemann Pick Disease Type C (NPC), representing significant areas of unmet medical need.
Innovations in Nasal Delivery
With proprietary powder formulations and specialized intranasal delivery devices, Oragenics is dedicated to pioneering new avenues for administering medications in the most effective manner possible. This strategic direction showcases the company's commitment to improving patient outcomes in neurology and infectious disease treatment.
Frequently Asked Questions
What is the significance of the public offering by Oragenics?
The public offering aims to raise funds for the continued development of ONP-002 and to support operating expenses, essential for the company's growth.
Who is the placement agent for this offering?
Dawson James Securities, Inc. is acting as the sole placement agent for Oragenics' public offering.
How much does Oragenics expect to raise from this offering?
Oragenics anticipates gross proceeds of approximately $4.45 million from the offering before fees and expenses.
Where can investors find more information about the offering?
Investors can access more information through the SEC's website or directly from Dawson James Securities, Inc. upon request.
What is ONP-002, and why is it important?
ONP-002 is a key product candidate being developed by Oragenics intended for treating neurological disorders, reflecting the company’s focus on addressing critical health challenges.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Court TV Announces Exciting Fall Primetime Lineup for 2024
- Moon Gaming Inc. Unveils Moon Poker: Exciting Tournaments Ahead
- American Financial Resources Announces Key Executive Changes
- MT Højgaard Holding A/S Announces Reduction in Shareholding
- Freddie Mac Unveils $233 Million Non-Performing Loan Offering
- Volaris Announces August 2024 Traffic Outcomes: 87% Load Factor
- Zynex Announces Participation in Upcoming Global Investment Event
- Novavax Announces Participation in Key Investor Conferences
- Edible Garden Expands Organic Herb Offerings in New Jersey
- Standard Completes Full Divestment in Suncor Energy Inc.
- Worlds Inc. Uplists to OTCQB, Enhancing Market Presence and Value
- iMD Companies Expands Riize Product Line with New Offerings
- AICA Announces Sixth Annual Fall Roundtable for Investors
- Canaan Inc. Plans Participation in Annual Crypto Conference
- PetSmart Announces Conference Call for Q2 2024 Financial Results
- APA Infrastructure Announces Cash Tender Offer for Senior Notes
- ROCKWOOL A/S Announces Share Buyback Program Updates
- Uruguay's Tender Offer Results and Bond Purchasing Details
- Daktronics, Inc. Reports Strong Q1 2025 Financial Results
- Kforce Inc. to Participate in J.P. Morgan Investor Conference
- Conagra Brands Announces First Quarter Earnings Release Date
- Torrid Holdings Inc. Reports Q2 Earnings Surpassing Estimates
- Waterdrop Inc. Reports Record Q2 Growth and Special Dividend
- Whitestone REIT Announces Q4 2024 Dividend Details
- Leslie's, Inc. Engages at Goldman Sachs Global Retailing Event
Recent Articles
- Teamsters' Strike: Ecology Curbside Services Faces Worker Discontent
- 3M Achieves Major Milestone with 300 Million Friction Shims
- Kymanox and SHL Medical Form Strategic Partnership for Drug Delivery
- Projected Growth of Wireless Gigabit Market to $138.8 Million
- Hackensack Meridian Health Foundation Gala Honors Eli Manning
- Digestion Resistant Maltodextrin Market Set for Remarkable Growth
- Kuehn Law Investigates Mergers of FBMS, IP, AFBI, CNDA Stocks
- We Card Awareness Month: Elevating Retailer Training Standards
- Eric Hargan Joins Walnut Hill Medical's Board of Directors
- Adial Pharmaceuticals Set for H.C. Wainwright Conference 2024
- PennantPark Investment Corporation Declares $0.08 Monthly Dividend
- L'Oréal Paris Celebrates 10 Women Changing the World
- Floodbase Achieves Enhanced Flood Mapping Accuracy with AI
- GridGain to Showcase Real-Time Data Innovations at Conferences
- Doré Copper Launches $4.62M Private Placement for Growth
- Providence Treatment Expands Services as Dual Diagnosis Provider
- Nordstrom Founders Propose $23 Per Share Takeover Bid
- Biofidelity Strengthens Leadership Team with Key Appointments
- Satellite Communication Market Set to Reach USD 188.94 Billion
- Exciting New Joint Venture: The Nemeth Bros Podcast Launch
- Egret Therapeutics Appoints Dr. Ron Cohen to Board of Directors
- Survey Reveals AI is Key Focus for Healthcare Leaders
- Aqua-Tots Swim School Launches First Location in New York
- Food Glazing Agents Market Expected to Reach $8.59 Billion
- Ocular Therapeutix to Showcase Innovations at Upcoming Events